Join us in this enlightening episode as we explore process economics with industry expert Brian Kelley. He is the Senior Vice President of Process Development at VIR Biotechnology. Unraveling the mysteries of cost management in antibody therapeutics, Brian sheds light on the intricate challenges faced by biotech scientists and engineers. Key Highlights: Discover the nuanced interplay between technical and cultural obstacles in process development.Navigate the labyrinth of cost drivers in antibody manufacturing, from raw materials to labor expenses.Learn the art of balancing speed, quality, and cost-effectiveness in bringing therapeutics to market.Tune in for a masterclass in maximizing efficiency and driving down costs in the dynamic landscape of biologics production. Connect with Brian Kelley: LinkedIn: https://www.linkedin.com/in/brian-kelley-3389375 Next Step: Enhance your bioprocess development strategy! Schedule your free assessment to propel your success: https://bruehlmann-consulting.com/assessment